DeJuSticia is an investigation centre created in 2003 by a group of university professors to promote social inclusion, democracy, the State of law and human rights in Colombia and Latin America.

DeJuSticia es un centro de investigación creado en 2003 por un grupo de profesores universitarios para promover la inclusión social, la democracia, el estado de derecho y los derechos humanos en Colombia y América Latina.

DeJusticia est un centre d’investigation créé en 2003 par un groupe de professeurs d’université qui promeut l’intégration sociale, la démocratie, l’Etat de droit et les droits humains en Colombie et en Amérique Latine.

Dejusticia

The 63rd session of the UN Human Rights Council brings together Member States, UN experts, civil society and other stakeholders to consider a wide range of human rights issues. The session provides an important opportunity to advance discussion of the human rights implications of drug policies and to promote approaches grounded in human rights, public health, evidence and the meaningful participation of affected communities.

The 63rd session of the UN Human Rights Council offers important opportunities to advance scrutiny of the human rights impacts of drug policies and promote approaches grounded in human rights, public health and evidence. Drug policy will feature prominently during the session, including through two important reports focusing respectively on the impact of drug policies on women and girls and on racial discrimination in drug law enforcement. Civil society, UN experts and Member States will also come together through a series of side events addressing gender, racial justice, Indigenous Peoples’ rights and broader efforts to bring international drug policy into closer alignment with human rights.

Two particularly significant reports dedicated to drug policy will be presented during HRC63.

OHCHR study on the impact of drug policies on the rights of women and girls (A/HRC/63/56)

 examines the human rights impacts of drug laws, policies and programmes on women and girls; efforts to mainstream gender and ensure women’s participation in the development, implementation, monitoring and evaluation of drug policies; and approaches to addressing the specific needs of women and girls.

Expert Mechanism to Advance Racial Justice and Equality in Law Enforcement

, alongside the report of its country visit to Colombia, 

. The reports examine how the design and enforcement of drug laws and policies affect Africans and people of African descent, tracing the historical and structural roots of racial discrimination in drug control and addressing impacts including racial profiling, over-incarceration, excessive use of force, arbitrary arrest and detention, and harsher sentencing.

HRI briefing: Drug policy opportunities at HRC63

Harm Reduction International has published a briefing mapping the main opportunities for advancing drug policy issues throughout the 63rd session. In addition to the reports highlighted above, the briefing identifies discussions touching on the right to health, the death penalty, Indigenous Peoples’ rights, racial justice, arbitrary detention and Universal Periodic Review outcomes, and sets out opportunities for Member States and civil society to bring the human rights consequences of punitive drug policies into these debates.

63rd Human Rights Council: Drug Policy Opportunities 

A number of side events will provide spaces for Member States, UN mechanisms, civil society and affected communities to discuss the intersections between drug policy and human rights during HRC63.

Women, Girls and Drug Policies: Advancing a human rights approach

28 September | 13:00–14:00 | Room V, Building A and online


Organised by OHCHR, the event will present key findings from its report on the impact of drug policies on women and girls, highlight promising practices in implementing human rights-, health-, gender-sensitive and evidence-based drug policies, and strengthen dialogue between Council members, UN entities, affected communities and civil society.

Drug Control and Human Rights: from parallel universes to emerging convergence

29 September | 12:00–13:00 | Room Concordia 1


Organised by Harm Reduction International, this event will examine the growing convergence between drug control and human rights over the past two decades. Discussions will consider the increasing attention paid by UN human rights mechanisms to the harms of punitive drug policies, how communities and civil society can use international human rights standards in their advocacy, and opportunities to advance more coherent and rights-based drug policies.

Systemic Racism and Drug Policy Enforcement

30 September | 12:00–13:00 | Room V, Building A and online


Co-hosted by the Expert Mechanism to Advance Racial Justice and Equality in Law Enforcement and OHCHR, the event will explore systemic racism in drug policy and law enforcement, building on the Expert Mechanism’s findings on the impact of drug laws and policies on Africans and people of African descent. It will bring together Member States, UN entities and civil society to discuss discriminatory impacts and pathways towards drug policies grounded in human rights, public health and racial justice.

From Flawed Review to Real Change: Indigenous and peasants’ rights and the future of the coca leaf

1 October | 13:00–14:00 | Room Concordia 1 and online


Organised by the International Drug Policy Consortium, this event will bring together civil society, UN experts and government officials to discuss the future of the coca leaf following its international review, including possible mechanisms to protect the plant and ongoing initiatives in the Andean region. Crucially, the discussion will feature the perspectives of Indigenous coca farmers.

Extra Punishment: Violence Against Women in the Fight Against Organized Crime

1 October | 14:00–15:00 | Room Concordia 1


Co-organised by Centro de Estudios Legales y Sociales (CELS), Dejusticia, Elementa and Mujeres Libres, this event will examine how policies targeting organised crime produce disproportionate and additional harms for women in Argentina, Colombia and Mexico. Discussions will address impacts across arrest, judicial proceedings and incarceration, including physical and sexual violence, extortion, violations of defence rights, incrimination by association, and barriers to prison benefits and alternatives to incarceration.

Youth and Drugs: Rethinking the Rules / Les jeunes et la drogue : repenser les règles


30 September | 18:30–20:00, followed by a reception | Room MS150, University of Geneva (UNIGE), Uni Mail
Organised by the Global Commission on Drug Policy, Geneva Health Forum and the Faculty of Medicine at the University of Geneva, this satellite event will examine how drug policies affect the rights, health and well-being of children and young people. Following the launch of the Global Commission’s new policy brief, 

Making Children and Young People Visible in Drug Policy: A Child Rights-Based Agenda for Reform

, the discussion will address punitive approaches to drugs, meaningful participation by young people, human rights, and evidence on prevention, treatment, harm reduction and public health. 

63rd session of the UN Human Rights Council

The Working Group on Women and Incarceration in Latin America analyses how the fight against organised crime affects women in contact with prison systems, as well as their families and children. To find out more, please read the information below in Spanish.

El crimen organizado aglomera a las estructuras que comercializan con bienes ilícitos, y/o emprenden medios ilícitos para conseguir bienes lícitos, debido a la prohibición o falta de regulación estatal. Las actividades pueden ser trata de personas, extorsión, tráfico de armas, explotación de recursos naturales, minería y tráfico y producción de drogas; esta última es el principal sector en América Latina. Generan una extracción de renta y dinámicas monopólicas, cuyos ingresos son destinados a incrementar el poder de esas estructuras, en términos de control de territorio, inversión en otros mercados, acumulación de riqueza o influencia política. Sus modelos de organización y trabajo son diversos. Algunos son grupos criminales consolidados de gran escala que han empezado a funcionar como corporaciones transnacionales; mientras que otros son agrupaciones barriales y familiares con menor alcance. Más allá de su variedad, el crimen organizado es una de las principales amenazas para el desarrollo social, la seguridad ciudadana y la estabilidad política de América Latina. Sus consecuencias negativas son observables en las altas tasas de homicidios en varios países de la región y en el alza de la violencia letal.

Los países de América Latina han adoptado acciones diversas para la persecución de estos grupos. En el último par de años, Argentina experimentó un auge de los discursos bélicos en torno al crimen organizado que resultó en la aprobación de diversas reformas al sistema de seguridad y justicia. Una de ellas es el traslado del Servicio Penitenciario Federal (SPF) del Ministerio de Justicia al Ministerio de Seguridad Nacional. En Colombia, el gobierno de Gustavo Petro abrió frentes de negociación con grupos criminales bajo la política de Paz Total, estableciendo ceses al fuego bilateral; mientras que la legislación colombiana mantiene la persecución penal para actores menores. México ha sostenido una tendencia a la militarización de las instituciones civiles de seguridad pública; entre las que se destaca la incorporación de la Guardia Nacional a la órbita de la Secretaría de Defensa Nacional. La mayor parte de estas acciones intensifican las lógicas punitivas debilitando los avances para promover una comprensión integral del fenómeno criminal, enfocada en la prevención del delito y que atienda las desigualdades estructurales. Así pues, diferentes actores nacionales han impulsado la implementación de modelos de seguridad sin mecanismos para la protección de derechos humanos, la erradicación de la violencia de género y la rendición de cuentas.

La falta de perspectiva de derechos humanos y de género en las respuestas al crimen organizado es preocupante. Las mujeres privadas de la libertad en América Latina están recluidas en centros penitenciarios en condiciones deplorables que ponen en riesgo el bienestar e integridad de las personas. Además de las fallas estructurales de los sistemas penitenciarios, enfrentan violencias, marginalización y otras situaciones específicas del género. Principalmente, deben afrontar la expectativa e imposición de mantener las responsabilidades de cuidado de sus hijos, hijas y otros dependientes, a pesar de estar privadas de la libertad. Una carga similar asumen las mujeres en el exterior que tienen a sus familiares y parejas detenidos. Además de esta distribución inequitativa del cuidado, quienes están en contacto con la prisión ven erosionadas sus redes de cuidado y apoyo. Adicionalmente, se debe considerar que esta población ha crecido un 212 % entre 2000 y 2024 como consecuencia del despliegue de políticas de drogas punitivas que persiguen, de manera desproporcionada, a mujeres provenientes de contextos caracterizados por la falta de oportunidades, que sufren violencia de género y son discriminadas en el acceso a la justicia.

Distintas agrupaciones y redes han trabajado para hacer frente a esta situación; entre ellas, el Grupo de Trabajo Mujeres y encarcelamiento (GT) creado en 2015. A través de una articulación transnacional, el GT ha impulsado la despenalización del consumo y los mecanismos alternativos a la prisión por delitos menores de drogas para mujeres en condiciones de marginación social, como la amnistía, el arresto domiciliario y la sustitución de la pena por la prestación de servicios sociales. Sin embargo, la tendencia al aumento de las mujeres privadas de la libertad ha experimentado poco o nulo cambio en los últimos cinco años. En Argentina y México, este grupo ha crecido en una proporción mayor que la población total en reclusión. En Colombia descendió el número total de mujeres privadas de la libertad, en particular de las relacionadas con el tráfico de estupefacientes, pero existe un alza por otros delitos, como el tráfico y porte de armas de fuego.

Así pues, en América Latina convergen la intensificación de las lógicas punitivas para hacer frente al crimen organizado y el crecimiento de las mujeres privadas de la libertad. En este escenario, detectamos una profunda falta de información sobre los impactos que tienen el crimen organizado y las respuestas estatales en las mujeres que están en contacto con los sistemas penitenciarios, tanto sobre aquellas que están o estuvieron privadas de la libertad —con o sin condena— como sobre las familiares de personas en reclusión. En otras palabras, se desconoce el castigo extra que recae sobre las mujeres que son procesadas y condenadas por participar en grupos criminales.

En 2025, organizaciones integrantes del GT de Argentina, Colombia y México unimos esfuerzos para diagnosticar los modos en que las políticas de persecución al crimen organizado afectan a las mujeres en contacto con los sistemas penitenciarios, y visibilizar las dimensiones de su participación en los mercados ilícitos y las situaciones de violencia y vulnerabilidad. Frente a un tema amplio e inexplorado, buscamos responder las siguientes preguntas: ¿Cómo impacta la persecución del crimen organizado en la judicialización y la reclusión de las mujeres? ¿Cómo afecta esta persecución a la vida de las familias e infancias? Esta investigación se realizó a través de entrevistas a mujeres en contacto con los sistemas penitenciarios, seleccionadas a partir de las estrategias de incidencia y acción comunitaria que ha emprendido cada organización en su país.

El documento sistematiza los principales hallazgos de la investigación y está dividido en cuatro secciones. Primero, expone las formas de involucramiento y participación en el crimen organizado. Las dos secciones siguientes describen los impactos de las políticas de persecución del crimen organizado en las mujeres en contacto con el sistema penitenciario, así como sobre sus hijas, hijos y otros familiares. La primera desarrolla las experiencias durante la judicialización y la segunda, durante el encarcelamiento. Esta sección también despliega los efectos y funcionamiento de tres políticas concretas: traslados arbitrarios, regímenes restrictivos penitenciarios y obstrucción a medidas alternativas al encarcelamiento. Por último, se presentan los riesgos del modelo actual de combate al crimen organizado para los derechos humanos y la igualdad de género. También, se realizan recomendaciones a los Estados para transformar el enfoque de las políticas de persecución y responder a las vulneraciones de derechos que experimentan las mujeres fuera y dentro de prisión.

Extra punishment: Violence against women in the fight against organised crime

The Working Group on Women, Drug Policy and Incarceration analyses how punitive drug policies have driven the incarceration of women in Latin America and proposes gender-sensitive and intersectional responses. More information, in Spanish, is available below.

Entre 2000 y 2024, la población de mujeres privadas de la libertad creció un 212% en América Latina. Este incremento tiene una de sus explicaciones en el despliegue de políticas de drogas punitivas que persiguen, de manera desproporcionada, a mujeres provenientes de contextos con falta de oportunidades, que experimentan violencia de género y son discriminadas en el acceso a la justicia. En respuesta a este escenario, en 2015, organizaciones de la sociedad civil, investigadoras y activistas conformaron el Grupo de Trabajo sobre Mujeres, Políticas de Drogas y Encarcelamiento (GT, en adelante). Su objetivo es reducir el número de mujeres privadas de la libertad en América Latina mediante la generación de investigación y recomendaciones de política pública, desde un enfoque de género e interseccional.

Contributions from the Working Group on Women, Drug Policy and Incarceration

During the General Debate of Item 3 at the 60th session of the Human Rights Council, Harm Reduction International, jointly with ACAT-Liberia, International Bar Association's Human Rights Institute, Dejusticia, HAYAT, ELEMENTA, International Drug Policy Consortium, Dianova International, Parliamentarian for Global Action, Amnesty International, International Network of People Who Use Drugs, and EHRA delivered a statement highlighting the state of the death penalty for drug offences and the need for drug policy reform as part of the abolition advocacy.

The co-signatories of this statement welcome the reports calling on States to refrain from imposing the death penalty for drug offences—a stance firmly grounded in international human rights law and standards, which limit this punishment to the ‘most serious crimes’. Drug offences fall outside this threshold.

Yet, in 2024 alone, at least 615 individuals, likely many more, were executed for drug offences worldwide—marking a dramatic 32% increase over the previous year—and accounting for nearly 40% of all confirmed global executions.

Iran remains at the epicentre of this crisis, being responsible for 79% of all known drug-related executions in 2024. Most alarmingly, Saudi Arabia recorded a staggering 122 executions—marking a 6,000% increase. It signals a renewed and unforgiving commitment to capital punishment as a tool of drug control. Concerningly, both figures are set to be higher by the end of 2025.

This regression is not inevitable. After positive developments in Pakistan and Malaysia in 2023, in June 2025 Vietnam removed the death penalty for certain drug crimes—changes that benefitted, or can benefit, hundreds on death row.

But meaningful progress requires international leadership and drug policy reform. We call on member states to continue to publicly condemn this cruel practice, develop coherent alternatives rooted in public health and human rights, and ensure that no funding for drug control efforts that risk contributing to executions.

60th session of UN Human Rights Council: Joint statement on death penalty and drug policy

The following statement was submitted for the consideration of the Expert Mechanism on the Rights of Indigenous Peoples (EMRIP), and summarised in an oral statement shared with the Interactive Dialogue held with the EMRIP during the 60th regular session of the Human Rights Council, on 24 September 2025. 

A full recording of the Dialogue is available here

 and the oral statement can be found further below.

In this joint declaration, we draw the attention of the Expert Mechanism on the need to ensure that international and national drug policies are fully aligned with the rights of Indigenous Peoples – in particular the right to their traditional medicines and to maintain their health practices. Unfortunately, historically the rights of Indigenous communities have been mostly sidelined, ignored or undermined. This is particularly the case in relation to the coca leaf.

In the Andean-Amazonian region, the coca leaf has been protected by Indigenous Peoples, cultivated it in small quantities, and used for traditional uses as part of their ancestral heritage for millennia.

And yet, the coca leaf was included in Schedule I of the 1961 Single Convention on Narcotic Drugs, a historical error justified at the time by racist and colonialist arguments – and which is now at odds with a number of international legal instruments that protect the use of the plant as an expression of the cultural, traditional, nutritional and medicinal practices of Indigenous Peoples.

The World Health Organisation now has the opportunity to repair this historical error, as it is currently conducting a critical review of the coca leaf – a review that could lead to the removal of the plant from the 1961 Convention. The WHO will delineate its recommendation on the matter at its 

This critical review is a key step towards decolonising drug policy and protecting the rights of Indigenous Peoples to cultivate and use the coca leaf.

Nationally, some countries have already established mechanisms to protect the coca leaf for their Indigenous communities. Bolivia withdrew from the 1961 Single Convention and re-accessed it with a reservation on the coca leaf, enabling a national legally regulated market for the plant. When ratifying the 1988 Convention, Colombia made a reservation on the use of the coca leaf as part of the culture of Indigenous Peoples, and the country’s 1986 Statute on Drugs allows for a differentiated treatment for the coca leaf cultivated in Indigenous territories.

The removal of the coca leaf from the UN drug control treaties would enable the creation of national and international markets for the coca leaf, as well as the protection of Indigenous Peoples’ right to cultivate and use the plant, via mechanisms such as the Nagoya Protocol of the Convention on Biological Diversity, the Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge, or protections under the UNESCO World Heritage.

make an official statement in support of human rights-oriented drug policies that fully respect the rights of Indigenous Peoples

, and to call on the WHO to adequately reflect the views and recommendations of indigenous Peoples as it elaborates its recommendations in relation to the coca leaf.

raise awareness of this issue at the Permanent Forum on Indigenous Peoples’ Rights

, requesting the Forum to also make an intervention at the WHO’s session on 20 October.

Finally, we strongly encourage the Expert Mechanism to 

consider conducting a study on the impacts of drug policies on the rights of Indigenous Peoples

 – including their right to self-determination, free and informed consent, and enjoyment of their traditional medicines.

Alianza por la Vida y la Dignidad en Los Yungas

PLATAFORMA COLI: Coca Orgánica Libre e Informada 

Joint statement at the interactive dialogue with the Expert Mechanism on the rights of Indigenous Peoples (EMRIP) 

My name is Pedro Arenas, I am representing Viso Mutop and the International Consortium, IDPC. I live in Guaviare, a region located in the western part of the Colombian Amazon.

The coca leaf, which has been fundamental to Andean-Amazonian Indigenous cultures for millennia, was wrongly classified in the 1961 Single Convention on Narcotic Drugs, based on colonial and racist arguments. This classification contradicts international protections for the cultural, medicinal and nutritional practices of indigenous peoples.

The World Health Organisation is currently conducting a critical review of the status of the coca leaf and has a unique opportunity this October to correct this error. The review is a fundamental step towards decolonising drug policy and guaranteeing indigenous rights.

Countries such as Bolivia and Colombia have already taken steps to protect the coca leaf in Indigenous communities. Removing the plant from international treaties will ensure that Indigenous rights are protected under instruments such as the Nagoya Protocol and UNESCO frameworks.

On behalf of six organisations, we urge the Expert Mechanism to:

publicly support human rights-based drug policies;

promote the consideration of Indigenous perspectives in the WHO critical review process;

raise awareness of this issue in the Permanent Forum; and

conduct a specific study on the effects of drug policy on Indigenous rights.

Decolonising drug policy: Protecting the coca leaf and Indigenous rights – Statement to the Expert Mechanism on the Rights of Indigenous Peoples

Thirty-five years since the first International Harm Reduction Conference in Liverpool, United Kingdom, in April 2025 we as a global collective of front-line health workers, academics, advocates, policy-makers, politicians, UN representatives, people who use drugs, sex workers and people working in the criminal legal justice system, gathered in Bogota, Colombia to build momentum towards a more just, fair and rights-based drug policy architecture that protects lives and restores dignity for all. Over four days, we platformed thought leaders, amplified advocacy for change and shone a light on local innovations in harm reduction.

This year’s conference theme ‘Sowing Change to Harvest Justice’ draws inspiration from Colombia’s efforts to reform drug policy and from the region’s shift towards addressing drug-related issues through public health, social justice, and environmental sustainability. HR25 spotlighted the ways in which prohibitionist drug policies drive and are derived from racism, patriarchy and colonial control, whilst elevating Global South leadership and the decolonization of drug policy.

Colombia’s courage in speaking out against a drug policy system that engenders violence and harm has created a fracture in the once seemingly intractable prohibitionist agenda. This, along with its efforts coordinating a 

coalition of member states and civil society organizations that are pushing for a review of the international drug control regime

, has created the conditions for change. On 14th March 2025, Colombia and its allies secured the adoption of an unprecedented resolution at the Commission on Narcotic Drugs (CND), initiating the first ever independent external review of the international drug control system. The Independent Expert Panel is tasked with developing a set of recommendations to enhance treaty implementation and international obligations of relevance for drug policy. 

Delegates of HR25, and as part of a global community of harm reduction and drug policy reform advocates and practitioners and of communities most impacted by punitive drug policies:

We recognize this independent review as an historic opportunity to critically assess the impact of current drug policies, that have included devastation and destruction, on people, communities and ecology. Such an opportunity cannot be wasted or left to wither away.

The strong calls from the international community to actively listen to the Colombian experience with the war on drugs, need to be matched with clear commitments and funding for reform opportunities. We request that the Colombian government, in reaffirming its leadership, provide funding for the setup, establishment, and operation of the Independent Expert Panel. We strongly urge other member states to co-sponsor the Panel, which must be fully funded to succeed in its mandate.

We stress the importance of ensuring that the Independent Expert Panel is diverse, transparent, interdisciplinary and technically robust, and that it centres the voices and experiences of the most affected communities, serving as a turning point for global drug policy transformation.

We affirm our commitment, as communities, civil society, academics and researchers, to work productively with the Panel, as well as with member states and other relevant actors, to ensure that the review process is meaningful, transparent, substantive and powerful.

We reaffirm our commitment to fight for a rights- and evidence-based drug policy framework that is fair, equitable and just; for a system that empowers people whose lives include drugs and facilitates innovative harm reduction approaches that are people-centered, respect autonomy, are fit-for-purpose and free from morally driven prejudice and discrimination.

On behalf of HR25, we thank Colombia for its unwavering courage, its commitment to drug policy reform, and for hosting HR25. Let HR25 be a pivotal chapter where words are translated into action, and where we, all together, make the most of this historical, once in a lifetime opportunity to change the course of drug policy: from prohibition to liberation, from enacting harm to restoring justice, from generating destruction to empowerment and community-building.

The Harm Reduction International Conference has come to an end: what happens next?

“Justice condemns women with a double penalty for being a woman… especially as a low-income woman, you’re invisible in the system until you commit a crime. Then, they finally see you.” —Nora Laura Calandra, co-founder of La Rama de Libertadxs y Familiares.

The incarceration of women is growing at alarming rates worldwide and in Latin America it is driven by strict drug laws, with devastating consequences for the women impacted and their families. Their stories unveil contexts of poverty, lack of opportunity, and physical and sexual violence, and also reveal the discrimination of unjust legal systems and societies plagued by stigmatization and patriarchal attitudes. But they are also stories of resilience, as women coming out of prison in Latin America today are organizing and fighting for their human rights and the right to live with dignity.

In response to the growing crisis of women’s incarceration in Latin America, in 2015 organizations, experts and activists created a Working Group on Women, Drug Policies, and Incarceration, led by the Washington Office on Latin America (WOLA), the International Drug Policy Consortium (IDPC), and the Colombian NGO, Centro de Estudios de Derechos, Justicia y Sociedad – Dejusticia. Our objective is to significantly reduce the number of women deprived of liberty in Latin America, providing analysis and public policy recommendations and participating in advocacy initiatives at the international, regional, and national levels.

The purpose of this report is to reflect on almost ten years of collective research and joint advocacy by the working group, its achievements and disappointments, as well as challenges and opportunities for the future.

Justice is setting them free: Women, drug policies, and incarceration in Latin America

Thursday, 12 October 2023 / 15:00 - 16:30 (CET - Vienna)

The event will be available in English and Spanish.

As Vienna prepares for a high-level ‘mid-term review’ in March 2024 to take stock of progress made and challenges remaining for the international drug control regime, the past 10 months have already seen a number of important developments from across the United Nations system. From New York and the adoption by vote of a bold new General Assembly resolution on drugs in December 2022, to Geneva and the adoption of the third Human Rights Council resolution on drug policy paving the way for the new OHCHR report on drug policy, to the ongoing preparations in Vienna and the Commission on Narcotic Drugs – there is a great deal to take stock of and a busy period of activity approaching.

This online event will shine a light on some of the key UN developments, and their implications for the ongoing push for drug policies that advance social justice and human rights. The International Drug Policy Consortium (IDPC) will present their comprehensive 

, the UN Office of the High Commissioner for Human Rights (OHCHR) will present their new report on the human rights implications of drug policy, and participants will have the opportunity to learn about and discuss these and other key developments.

, Global Commission on Drug Policy, former Minister of Justice and Human Rights of Peru and former UN Special Rapporteur on the on the independence of judges and lawyers

, Advisor on Human Rights and Drug Policy, Office of the United Nations High Commissioner for Human Rights

, Head of Research and Communications, International Drug Policy Consortium

, Ambassador, Permanent Representation of Ghana to the United Nations in Vienna

, Senior Coordinator - Drug Policy, Dejusticia

Boiling point: Understanding new developments in global drug policy, and why they matter 

Wednesday, 20th September 2023, 13:30 - 15:00 (Geneva - CET)


Organised by the Office of the High Commissioner for Human Rights, in collaboration with Albania, Brazil, Colombia, Greece, Guatemala, Mexico, Paraguay, Portugal, Switzerland, Uruguay, UNAIDS, Amnesty International, Centro de Estudios Legales y Sociales, Dejusticia, the Global Commission on Drug Policy, Harm Reduction International, the Helsinki Foundation for Human Rights, the International Drug Policy Consortium, the International Network of People Who Use Drugs and the Open Society Foundation.

The Panel will provide a platform for international human rights experts, representatives of State and civil society organisations to discuss findings and recommendations of the report of the Office of the United Nations High Commissioner for Human Rights on ‘

Human rights challenges in addressing and countering all aspects of the world drug problem

Abdoul Thioye, Chief, Rule of Law, Equality and Non-discrimination Branch, OHCHR

Nekane Lavin, Human Rights Officer, OHCHR

Ann Fordham, Executive Director, International Drug Policy Consortium

Haryati Binti Jonet, Member, Asian Network of People Who Use Drugs

José Ignacio Juarèz Garcia, Director, Human Rights, Ministry of Foreign Affairs, Mexico

Hélène Tigroudja, Member, Human Rights Committee

Suki Beavers, Director, Gender Equality, Human Rights and Community Engagement, UNAIDS

Diego García-Sayán, Commissioner, Global Commission on Drug Policy

Dejusticia

Region

Translations

Related Content